Showing results (141-150 of 156) with videos related to
Sort By:
Pageof 16
Psycho-Oncology|April 15, 2021
Improved cancer coping from a web-based intervention for prostate cancer survivors: A randomized controlled trialErin K Tagai, Suzanne M Miller, Shawna V Hudson, et al.The Journal of Urology|April 28, 2015
Circulating Tumor Cells as Potential Biomarkers in Bladder CancerAjjai Alva, Terence Friedlander, Melanie Clark, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2002
Characterization of a novel prostate-specific antigen-activated peptide-doxorubicin conjugate in patients with prostate cancerRobert S DiPaola, John Rinehart, John Nemunaitis, et al.Neurosurgery|January 4, 2022
Importance of Cobalt-60 Dose Rate and Biologically Effective Dose on Local Control for Intracranial Meningiomas Treated With Stereotactic RadiosurgeryMichael Huo, Melanie Rose, Monique van Prooijen, et al.Neurosurgery|November 7, 2019
Predictors of Outcomes After Focused Ultrasound ThalamotomyVibhor Krishna, Francesco Sammartino, Rees Cosgrove, et al.Technology in Cancer Research & Treatment|August 4, 2009
Advances in technology for intracranial stereotactic radiosurgeryArjun Sahgal, Lijun Ma, Eric Chang, et al.World Neurosurgery|June 7, 2021
Radiation Dose Rate, Biologically Effective Dose, and Tumor Characteristics on Local Control and Toxicity After Radiosurgery for Acoustic NeuromasConrad Josef Villafuerte, David B Shultz, Normand Laperriere, et al.Movement Disorders : Official Journal of the Movement Disorder Society|April 28, 2018
Neurological adverse event profile of magnetic resonance imaging-guided focused ultrasound thalamotomy for essential tremorPaul S Fishman, W Jeffrey Elias, Pejman Ghanouni, et al.Cancer|October 20, 2020
Health-related quality of life outcomes for the LEAP study-CALGB 70305 (Alliance): A lymphedema prevention intervention trial for newly diagnosed breast cancer patientsMichelle J Naughton, Heshan Liu, Drew K Seisler, et al.Cancer|October 20, 2020
A randomized study to prevent lymphedema in women treated for breast cancer: CALGB 70305 (Alliance)Electra D Paskett, Jennifer Le-Rademacher, Jill M Oliveri, et al.Pageof 16